Cookie Notice
We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.



Over one million women have used the Oncotype DX test to help determine the right treatment for their early-stage breast cancer.

Not All Breast Cancer is The Same

The Oncotype DX test provides a personalized score based on the biology of your tumor and can help tailor treatment decisions for your individual cancer. Nearly a million women have taken the Oncotype DX test to date. Watch the video to hear some of their stories.
Recurrence Scores

With the Oncotype DX Test, Outcomes Matter

The Oncotype DX Breast Recurrence Score test is a genomic test for early-stage breast cancer that can help guide treatment decisions for the best possible outcome. Watch our Outcomes Matter video to learn more.

Patient Stories

Read personal stories of breast cancer survivors and how the Oncotype DX test helped guide their treatment decision.